Alan Cass

Medicine & Life Sciences

1. Chronic Renal Insufficiency 100%
2. Dialysis 78%
3. Kidney 54%
4. Chronic Kidney Failure 52%
5. Renal Replacement Therapy 46%
6. Northern Territory 37%
7. Systematic Reviews 31%
8. Glomerular Filtration Rate 29%
9. Renal Dialysis 28%
10. Acute Kidney Injury 27%
11. Kidney Diseases 25%
12. Health 24%
13. Meta-Analysis 23%
14. Randomized Controlled Trials 23%
15. New Zealand 22%
16. Kidney Transplantation 22%
17. Quality of Life 21%
18. Cardiovascular Diseases 21%
19. Transplants 20%
20. Confidence Intervals 20%
21. Health Services 18%
22. Mortality 18%
23. Blood Pressure 17%
24. Primary Health Care 17%
25. Nephrologists 16%
26. Registries 16%
27. Therapeutics 16%
28. Placebos 15%
29. Population 14%
30. Delivery of Health Care 14%
31. Transplantation 13%
32. Albuminuria 13%
33. Incidence 13%
34. Creatinine 13%
35. Guideline Adherence 12%
36. Cohort Studies 12%
37. Organ Transplantation 11%
38. Tissue Donors 11%
39. Type 2 Diabetes Mellitus 11%
40. Economics 11%
41. Tissue and Organ Procurement 10%
42. Peritoneal Dialysis 10%
43. Fish Oils 10%
44. Hematinics 10%
45. Outcome Assessment (Health Care) 9%
46. Omega-3 Fatty Acids 9%
47. Cost-Benefit Analysis 9%
48. Nephrology 9%
49. Chronic Disease 9%
50. Ezetimibe 9%